Seagen EBIT

Seagen (SGEN) currently reports a EBIT of $-810M as of September 2023. That compares with $-630M in the prior-year period — down 27.7% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore Seagen's EBIT history and peer comparisons.

Seagen's EBIT decreased from $-630M to $-810M — a 27.7% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Seagen's EBIT of $-810M is lower than the Healthcare sector average of $22B. That is roughly 103.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Seagen reported $-810M in EBIT as of September 2023. That compares with $-630M in the prior-year period — down 27.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-810M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for Seagen, and consider following SGEN for alerts when major investors trade the stock.